Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $203,920 - $256,680
-2,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $212,740 - $261,360
2,000 New
2,000 $259,000
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $842,592 - $1.05 Million
-10,050 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $1.08 Million - $1.37 Million
-15,000 Reduced 59.88%
10,050 $917,000
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $1.01 Million - $1.31 Million
15,000 Added 149.25%
25,050 $2 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $385,518 - $515,565
6,700 Added 200.0%
10,050 $695,000
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $175,573 - $271,350
3,350 New
3,350 $632,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Highland Capital Management Fund Advisors, L.P. Portfolio

Follow Highland Capital Management Fund Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.